Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) reported the agenda for its KOL virtual investor event taking place on Oct. 29 at 12:00 pm ET.
Presenters include Jim Hutchens, Imagin’s president and CEO; Dr. Ashish Kamat of Houston’s MD Anderson Cancer Center; Dr. Alexandre Zlotta of Toronto’s Mount Sinai Hospital; Dr. Mehrdad Alemozaffar of Kaiser Permanente in Los Angeles; and financial industry expert, Ron Insana.
The KOLs will share insight into the current state of bladder cancer imaging and the acute need for improved methods to help reduce recurrence and mortality.
“We are pleased to have an impressive roster of KOLs discussing the shortcomings of current bladder cancer imaging technologies,” Mr. Hutchens said in a statement.
“We are looking forward to presenting how Imagin is working to address these limitations with its i/Blue Imaging System, which has the potential to become the new standard-of-care in bladder cancer imaging,” he added.